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Abstract
Background: Protein phosphatase 2A (PP2A) is a serine/threonine-specific phosphatase displaying
vital functions in growth and development through its role in various signalling pathways. PP2A
holoenzymes comprise a core dimer composed of a catalytic C and a structural A subunit, which
can associate with a variable B-type subunit. The importance of the B-type subunits for PP2A
regulation cannot be overestimated as they determine holoenzyme localisation, activity and
substrate specificity. Three B-type subunit families have been identified: PR55/B, PR61/B' and PR72/
B", of which the latter is currently the least characterised.
Results: We deduced the sequences and genomic organisation of the different murine PR72/B"
isoforms: three genes encode nine isoforms, five of which are abundantly expressed and give rise
to genuine PP2A subunits. Thereby, one novel subunit was identified. Using Northern blotting, we
examined the tissue-specific and developmental expression of these subunits. All subunits are highly
expressed in heart, suggesting an important cardiac function. Immunohistochemical analysis
revealed a striated expression pattern of PR72 and PR130 in heart and skeletal muscle, but not in
bladder smooth muscle. The subcellular localisation and cell cycle regulatory ability of several PR72/
B" isoforms were determined, demonstrating differences as well as similarities.
Conclusion: In contrast to PR55/B and PR61/B', the PR72/B" family seems evolutionary more
divergent, as only two of the murine genes have a human orthologue. We have integrated these
results in a more consistent nomenclature of both human and murine PR72/B" genes and their
transcripts/proteins. Our results provide a platform for the future generation of PR72/B" knockout
mice.
Background
Protein phosphatase 2A (PP2A), one of the major serine/
threonine protein phosphatases in the cell, is involved in
the control of a large number of cellular events including
cell growth, intracellular signalling, DNA replication,
transcription, translation, cell differentiation and cell
transformation [1,2]. The key to understand how PP2A is
capable of regulating such diverse, and sometimes even
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opposite functions, is its structure. The core of PP2A con-
sists of a structural PR65/A subunit and a catalytic C sub-
unit, both existing in two isoforms, α and β. To this PP2A
dimer (PP2AD), a third regulatory B-type subunit can
bind. It is generally believed that the regulatory B-type
subunits target the phosphatase to distinct substrates and
intracellular localisations. At present approximately 20
regulatory B-type subunits have been described. Based on
their primary structure, they can be divided into three
families: PR55/B, PR61/B' (also called B56) and PR72/B"
[1]. They share two conserved A subunit binding domains
(ASBD) [3]. In theory, about 80 different combinations of
trimeric ABC holoenzymes can be formed. How many
actually exist in the cell, is unknown and most probably
differs in different tissues due to the tissue-specific expres-
sion of some PP2A subunits [1]. Furthermore, phosphor-
ylation and methylation of the catalytic C subunit play an
important role in the assembly of specific trimeric holoen-
zymes [4,5].
In the present study, we focus on the regulatory PR72/B"
subunit family named after the molecular weight of the
first identified member [6]. In mammals, sofar 6 members
have been described: PR72 [6], PR130 [6], PR70 [7],
PPP2R3L product [8], G5PR [9] and mPR59 [10], all shar-
ing a conserved region with two ASBDs important for
binding to PP2AD. Characteristically for this family, are –
in addition to both ASBDs – two Ca2+-binding EF-hand
motifs [11]. Mutation analysis of these EF-hand motifs
together with several binding and activity studies indicate
that Ca2+ can influence the heterotrimeric assembly and
catalytic activity of the B"-containing PP2A [11-14].
PR72 and PR130, the founding members of the B" family,
are two N-terminal splice variants with a different tissue
distribution pattern. PR72 is highly abundant in heart and
skeletal muscle and barely detectable in other tissues.
PR130, on the other hand, has a more widespread distri-
bution [6]. Both splice variants have a role in Wnt signal-
ling since they both regulate Naked Cuticle (Nkd)
function, yet apparently in opposite ways [15,16]. Fur-
thermore, addition of IQ-1, a compound which disrupts
binding of PR72 and PR130 to both PP2AD and Nkd,
results in prevention of embryonic stem cell differentia-
tion due to a change of co-activators associating with β-
catenin [17]. In addition, PR72-containing PP2A
(PP2AT72) is also responsible for the glutamate-dependent
dephosphorylation of Thr75 in dopamine- and cAMP-reg-
ulated phosphoprotein of 32 kDa (DARPP-32) in
dopaminoceptive neuronal cells of the striatum [12].
PR130-containing PP2A (PP2AT130) has been described as
an interacting protein of CG-NAP (centrosome and Golgi
localised PKN-associated protein), a scaffolding protein
that assembles several protein kinases (PKA, PKN) and
protein phosphatases (PP1, PP2AT130) on centrosome and
Golgi apparatus [18]. PP2AT130 is also suggested to be
involved in the calcium release from the sarcoplasmic
reticulum of heart cells as it can interact with the ryanod-
ine receptor type 2, a heart-specific Ca2+ channel found to
be hyperphosphorylated in some patients with heart fail-
ure [19]. In Xenopus laevis, an additional splice variant,
named XN73, has been found. This protein contains the
specific N-terminus of PR130 followed by a short tail of 7
amino acids and thus lacks the ASBD necessary for PP2AD-
binding. Consequently, this protein is not a regulatory
PR72/B" subunit strictu senso [7] but-based on its
sequence-might compete in binding to other cellular part-
ners of PR130.
After identification of PR48 as a B" subunit family mem-
ber which can bind Cdc6 [20] and therefore involved in
regulation of the cell cycle, it was found that PR48 repre-
sents a partial clone of a larger human B" subunit, PR70
[7]. Currently, two PR48-containing isoforms have been
described with different N-termini: PR70 and PPP2R3L
product. PPP2R3L product is mainly expressed in heart
and skeletal muscle [8], whereas PR70 is ubiquitously
expressed [7]. Recently, various links between PR70 and
cell cycle progression have been discovered. PR70 can
bind retinoblastoma protein (pRb), thereby regulating its
phosphorylation status following oxidative stress [13]
and it can associate with Cdc6 [14].
Another member of the B" subunit family is named G5PR.
It has a wide expression pattern and can bind both PP2AD
and PP5 [9]. Furthermore, G5PR can interact with GANP,
a DNA-primase which is selectively up-regulated in germi-
nal centre B cells after immunisation with T cell-depend-
ent antigens [9]. B-cell-specific G5PR knockout mice
display a decreased number of splenic B cells. This
enhanced cell death, specifically induced upon antigen
binding to the specific B cell receptor, is caused by an
increased activation of c-Jun NH2-terminal protein kinase
and Bim [21]. In parallel, T-cell-specific G5PR knockout
mice display a decreased number of thymocytes. The
enhanced cell death, mainly seen in CD4 and CD8 double
positive thymocytes, is accompanied by increased activa-
tion of both c-Jun NH2-terminal protein kinase and cas-
pase-3, but not Bim [22].
mPR59 is a mouse-specific B" subunit, discovered as an
interacting protein of p107, a Rb related protein [10]. No
human orthologue of mPR59 is found so far. It is
expressed in various tissues and overexpression can regu-
late p107 phosphorylation, causing an increase of cells in
the G1 phase of the cell cycle [10]. Furthermore, mPR59
co-purifies with the L-Type Calcium Channel Cav1.2, a
voltage-gated Ca2+ channel important for Ca2+ influx in
cells of the cardiovascular system, heart and brain [23].BMC Genomics 2008, 9:393 http://www.biomedcentral.com/1471-2164/9/393
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Undoubtedly, the generation of (additional) PR72/B"
knockout mice will be a valuable tool to obtain further
insights into the potential physiological roles of the PR72/
B" regulatory subunits. To provide a framework for the
generation and analysis of such PR72/B" knockout mice,
we present a comprehensive overview of the murine
PR72/B"-encoding genes, their exon/intron organisation,
their (alternative) transcripts and their developmental
and tissue-specific expression. Surprisingly and in contrast
to the murine PR55/B [24] and PR61/B' [25] families of
PP2A subunits, the murine PR72/B" subunits have
evolved somewhat differently compared to their human
orthologues. As a consequence the current PR72/B"
nomenclature is confusing, and we now propose some
changes to make it more consistent. At the cellular level,
we determine the subcellular localisation of the major
PR72/B" subunits and their ability to affect cell cycle pro-
gression upon overexpression. Evidence is presented for at
least one novel murine PR72/B" isoform, adding to the
high diversity of PP2A B-type subunits.
Results
The murine B" family isoforms
In mammals, four genes of the B" regulatory subunit fam-
ily of PP2A have been described, giving rise to six iso-
forms: PR72 [6], PR130 [6], PR70 [7], PPP2R3L product
[8], G5PR [9] and mPR59, an isoform sofar only found in
mice [10].
Upon searching the NCBI database for murine B" family
members via the BLAST algorithm, we retrieved the com-
plete protein sequence of two murine PR72 isoforms: the
human PR72 orthologue [GenBank:BAE21013] (referred
to as mPR72/B"α2) and a shorter variant missing the last
41 residues [GenBank:BAC28935] (referred to as mPR72/
B"α4). In addition, one mG5PR isoform [Gen-
Bank:NP_067504] (referred to as mG5PR/B"γ) and four
mPR59 isoforms were retrieved: mPR59 as described by
Voorhoeve  et al. [GenBank:AAC98973] (referred to as
mPR59/B"δ2) [10], two mPR59 variants containing dif-
ferent N-termini [GenBank:AAH59852 and BAE25309]
(referred to as mPR59/B"δ1 and mPR59/B"δ3 respec-
tively) and a mPR59/B"δ3 variant harbouring an alterna-
tive C-terminus [GenBank:AAH96544] (referred to as
mPR59/B"δ4). Additionally, two partial protein
sequences of murine PR130 homologues were retrieved,
one containing the first 615 amino acids of the PR130
specific N-terminus [GenBank:BAC31413] and the other
containing the last 203 amino acids of the specific N-ter-
minus followed by 12 additional residues [Gen-
Bank:BAC37349], resembling Xenopus XN73 (referred to
as mPR130/B"α3). Of the full-length mPR130 (referred to
as mPR130/B"α1), only a predicted sequence [Gen-
Bank:XP_135153] could be found.
To confirm these in silico data and to get an idea about the
abundancy of these clones, we scanned the NCBI database
for murine EST-clones containing the B"-specific N- or C-
termini. Only very few EST-clones were found carrying the
sequence of the mPR72 C-terminus lacking 41 residues
[GenBank:BE852268 and CA984544], the XN73-like
truncated mPR130 C-terminus [GenBank:AV356684] and
the alternative mPR59 C-terminus [GenBank:BB357167],
making it rather unlikely that murine B" family members
containing these termini (mPR130/B"α3, mPR72/B"α4
and mPR59/B"δ4) do abundantly exist. In contrast, five
EST-clones of the specific N-terminus of mPR59/B"δ3 and
multiple (> 15) EST-clones of the other B"-specific N- and
C-termini were found, suggesting that mPR72/B"α2,
mPR130/B"α1, mG5PR/B"γ, mPR59/B"δ1, PR59/B"δ2,
and PR59/B"δ3 are much more abundant, and probably
represent the main murine B" isoforms.
Since mPR59/B"δ1 and mPR59/B"δ3 are putatively novel,
and to further confirm their existence, we performed a
reverse transcription on NIH 3T3 and murine heart RNA
using primer E3 annealing in the mPR59 3' UTR. With the
resulting cDNAs as templates and the use of five different
primers, annealing with the specific N-termini of PR59/
B"δ1–4 (Bδ1, Bδ2, Bδ3/4) and/or the specific C-termini of
PR59/B"δ1–3 (E2) and PR59/B"δ4 (E1), we were able to
generate several DNA fragments, which after sequencing,
were shown to correspond to PR59/B"δ1, PR59/B"δ2 and
PR59/B"δ3. In vitro transcription-translation reactions of
these cDNAs revealed proteins of about 60 kDa (PR59/
B"δ1), 55 kDa (PR59/B"δ2) and 40 kDa (PR59/B"δ3)
(Figure 1A), implying that not only the messengers of
PR59/B"δ1,δ2,δ3 are present in murine cells, but that they
can also be translated into proteins. A cDNA for mPR59/
B"δ4 could not be amplified using this approach, con-
firming its low occurrence in the EST database.
A similar approach was undertaken to confirm the exist-
ence of the four mPR130/PR72 isoforms. In this case RT-
PCR of NIH 3T3 or murine heart RNA led to the amplifi-
cation of mPR130/B"α1 and mPR72/B"α2 cDNA, but not
of mPR130/B"α3 or mPR72/"α4. To confirm this at the
protein level, we prepared protein extracts of murine
embryonic fibroblast NIH 3T3 cells and several murine
adult tissues: heart, in which both human PR130 as PR72
are highly expressed [6]; adrenal gland, the tissue from
which the mPR130/B"α3 EST-clone [Gen-
Bank:AV356684] was isolated, and brain. Three antibod-
ies were used to perform immunoprecipitations of the
different mPR130/PR72 isoforms: a PR72 AB, raised
against full-length recombinant human PR72 [11]; a
PR130N AB, raised against the recombinant specific N-ter-
minus of human PR130 (AA 1–664) and a peptide PR72
AB, raised against the first 19 amino acids of the human
PR72-specific N-terminus. The results demonstrate immu-BMC Genomics 2008, 9:393 http://www.biomedcentral.com/1471-2164/9/393
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noreactivity at 140 kDa and 70 kDa, corresponding to
mPR130/B"α1 and mPR72/B"α2 (Figure 1B). No other
specific bands could be observed, even upon prolonged
exposure, confirming our in silico and RT-PCR analysis.
Consequently, it can be concluded that should the
mPR130/B"α3 and/or mPR72/B"α4 isoforms exist, their
expression would be very low or highly restricted in time
and/or space.
Together, six main B" family members are present in mice:
mPR130/B"α1, mPR72/B"α2, mG5PR/B"γ, mPR59/B"δ1,
mPR59/B"δ2 and mPR59/B"δ3, with mPR59/B"δ1 and δ3
being novel ones. A protein alignment of these murine B"
isoforms (Figure 2) reveals that they all share a conserved
region, harbouring both ASBD and both EF-hand motifs,
with the exception of mPR59/B"δ3 which misses 31
amino acids of the first ASBD. They mainly differ within
their N- and/or C-termini, which may be responsible for
isoform-specific functions. Surprisingly, no evidence of
murine PR70 and PPP2R3L product orthologues could be
found. The murine proteins most closely resembling these
isoforms are PR59/B"δ1 (58% identity, 66% similarity
with hPR70) and PR59/B"δ2 (57% identity; 66% similar-
ity with the PPP2R3L product).
Genomic organisation of the three murine B" genes
An alignment of the nucleotide sequences of the murine
PR72/B" isoforms suggests that all novel isoforms are the
result of alternative splicing of the genes encoding previ-
ously described members. By BLASTN analysis of the
murine genome using the murine cDNA sequences, we
could solve the genomic organisation of these three
murine B" genes (Figure 3). The intron-exon boundaries
were deduced by comparing the sequences obtained from
the genomic clones and the respective cDNAs. Almost all
boundaries were found to follow Chambon's rule (GT-
AG) for splice donor and acceptor sites [26] (Table 1).
The genomic organisation of the gene giving rise to the
murine PR130 and PR72 isoforms (3222402P14Rik, MGI:
2442104) was deduced from clone RP24-308L17 [Gen-
Bank:AC120390], containing the entire gene. To retain
the logic in the PR72/B" gene nomenclature, we propose
to rename this gene into Ppp2r3a, analogous to the human
PPP2R3A  gene. The mPR130/PR72 gene is located on
chromosome 9F1 (101 Mb). This region corresponds to
human chromosome 3q22, where PPP2R3A is located.
The mPR130/PR72 gene (Figure 3) spans approximately
106 kb and consists of 15 exons. In addition to the exons
giving rise to mPR130/B"α1 and mPR72/B"α2, we could
also locate both the exon containing the sequence of the
12 specific C-terminal amino acids of mPR130/B"α3
(exon 2), and the exon responsible for the premature end-
ing of PR72/B"α4 (exon 14B) at the correct sites within
the gene. Since PR72/B"α2 is the result of an intra-exonic
splicing event within exon 14, PR72/B"α4 might well be
the result of a splicing error at this position, possibly
explaining its low abundance. In the human PR130/PR72
gene (PPP2R3A), the exon responsible for the putative
generation of a human PR72/B"α4 isoform is also
present. The NCBI human EST database contains exactly
one EST [GenBank:CA427549] containing this exon. In
contrast, no sign of the specific C-terminal tail of either
mPR130/B"α3 or XN73 could be found in PPP2R3A. In
Diversity of the murine PR130/72 and PR59 isoforms Figure 1
Diversity of the murine PR130/72 and PR59 isoforms. A: Autoradiography of [35S]-labelled in vitro transcription-transla-
tion products of plasmids (1 μg) containing cDNA of murine PR59/B"δ1 (lane δ1), PR59/B"δ2 (lane δ2) and PR59/B"δ3 (lane 
δ3). B: Immunoprecipitation of mPR72/PR130 isoforms from different murine cells and tissues (N = NIH 3T3, H = heart, B = 
brain, A = adrenal gland) using pre-immunisation sera (as negative control) and three different PR72/PR130 antibodies: PR72rec. 
AB recognizes all putative PR72 isoforms and the PR130 isoforms which contain the common C-terminal region, PR130N rec. 
AB recognizes all PR130 isoforms, and PR72N pept. AB recognizes all PR72 isoforms.
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Alignment of the amino acid sequences of the murine B" isoforms Figure 2
Alignment of the amino acid sequences of the murine B" isoforms. Residues identical for all isoforms are shown in 
bold. The two ASBDs are marked in grey shade and the boxes represent the two conserved EF-hand motifs. For each isoform, 
the start Methionine is underlined. The first 8 lines represent only the specific sequences of the PR130 N-terminus.
70
PR130/B”D1M AATYRLVVS TVNHYSSVVI DRRFEQAIHY CTGTCHTFTH GIDCIVVHHS VCADLVHIPV SQFKDVDLNS
PR130/B”D1  VFLSHENGLS SAEDYPHQAL TGLPRGKKAS TFQNTCNLKD IAGEAISFAS GKIKEFSLEK LRNSNHAAYR
PR130/B”D1 KGRKVKSDSF NRRSVDFDLL CGHYNNDGTS PPFGLLRSSS VEEKSLSHRN SLDTNLTSML FQNLSEEDLV
PR130/B”D1 TQILEKHKID HFSSGTDIKM CLDILLKCSE DLKKCTDIIK QCIKKKSGGS ISEGSGNEVI SNSETVYMNV
PR130/B”D1 MTRLAYYLRK LPFEFMQSGN NETVDLTELI NNIPNLQLTP FSPLYGTEQP PKYEDIVHLS ALDSGQFQTV
PR130/B”D1 ELQDDKHNFK QTDIVKTTPN NTDSLCSLEV NDPGTLKPVQ LQSPLLTINH LENVSSGNLM ETLYIEEESD
PR130/B”D1 GKKSLLDKEQ KAENGQGQEP LQVNEHKEFS DHDTYLKKCP VSMQNEIGKI FEKPIMVHPS KEDSKLEVPT
PR130/B”D1 TDLRDQRHFV NPNSQEEIDK LLMDLESFSQ KMETSLGEPL AKGKSINSLN SHSHLTAQSH KDLEPKPIAS
630
PR130/B”D1  SAMEKVSPSC LTRIIENNGH KMEEEDRALL LRIMESIEDF AQELVECKSG RGSLSQEKEM MQILQETLTT
PR72/B”D2  .......... .......... .......... .......... .......... .......... MMIKETSLRR
PR59/B”G1 .......... .......... .........M APLTPRLQLK VDELF..RRW LGDPHTQRAL SHALRRI.RD
PR59/B”G2   .......... .......... .......... .......... .......... ....MPERPP IRALRRD.PD
PR59/B”G3   .......... .......... .......... .......... .......... .......... ..........
G5PR/B”J .......... .......... .......... .......... MDWKDVLRRR LASPNTDPKR KKSEQELKDE
700
PR130/B”D1  SSQPTPSVCR SPVGEKPKDS TSVVLIQQTP EVIKIQNKPE KKPATSFPPA ATLPSSPQPA SPVPCVSDVV
PR72/B”D2  DPDLRGELAF LARGCDFVLP SRFKKRLKSF QQTQIQNKPE KKPATSFPPA ATLPSSPQPA SPVPCVSDVV
PR59/B”G1   PGTTSDPAAA ATPDADPGNT TSDPNPASRP LPRPALRTTG PRTVHAHRKE EPPPQSPPPG HSVPA.....
PR59/B”G2   DPAVAQALAS LARGSD.... LVFPSRFQKW L.......RD FRQVHAHRKE EPPPQSPPPG HTVPA.....
PR59/B”G3   .......... .......... .......... .......... .......... .......... ..........
G5PR/B”J EMDLFTKYYS EWKGGRKNTN EFYKTIPRFY YRLPAEDEVL LQKLREESRA VFLQRKSREL LDNEELQN..
770
PR130/B”D1  NTPLSINIPQ FYFPEGLPDT C.SNHEQILS RIETAFKDIE DQKADIHEMG RIAKVCGCPL YWKAPMFRAA
PR72/B”D2  NTPLSINIPQ FYFPEGLPDT C.SNHEQILS RIETAFKDIE DQKADIHEMG RIAKVCGCPL YWKAPMFRAA
PR59/B”G1   .......... FYFPCGRPPP RPQDTEDAIA LVECAFEGLP RGRAGLGDMA VVAKACGCPL YWKAPLFYAA
PR59/B”G2   .......... FYFPCGRPPP RPQDTEDAIA LVECAFEGLP RGRAGLGDMA VVAKACGCPL YWKAPLFYAA
PR59/B”G3   .......... .......... .......... .......... .......... .......... ..........
G5PR/B”J .......... LWFLLDKHQI PPMIGEEAMI NYEN.FLKVG EKAGPKCKQF FTAKVF.... ...AKLLHTD
840
PR130/B”D1  GGEKTGFVTA QSFIAMWKKL LSNRHDDAAK FIWLLAKPSC SYLEQEDFIP LLQDVVDTHP GLTFLKDAPE
PR72/B”D2  GGEKTGFVTA QSFIAMWKKL LSNRHDDAAK FIWLLAKPSC SYLEQEDFIP LLQDVVDTHP GLTFLKDAPE
PR59/B”G1   GGERTGSVSV HMFVAMWRKV LLTCHDDAAR FVRLLGHPGC SGLIQEDFVP FLQDVVNSHP GLAFLRAAKD
PR59/B”G2   GGERTGSVSV HMFVAMWRKV LLTCHDDAAR FVRLLGHPGC SGLIQEDFVP FLQDVVNSHP GLAFLRAAKD
PR59/B”G3   .........M PLTPPIAVRF TVNPSDPALT PPTALG.PAH TALTLTVITA LALPLMPGHT HSPHINYSDS
G5PR/B”J SYGRISI..M QFFNYVMRKV WLHQTRIGLS LYDVAGQ... GYLRESDLEN YILELIPTLP QLDGLE..KS
910
PR130/B”D1  FHSRYITT.. ..VVQRIFYT VNRSWSGKIT STEIRKSNFL QTLALLEEEE ..DINQITDY FSYEHFYVIY
PR72/B”D2  FHSRYITT.. ..VVQRIFYT VNRSWSGKIT STEIRKSNFL QTLALLEEEE ..DINQITDY FSYEHFYVIY
PR59/B”G1   FHSRYITT.. ..VIQRIFYT VNRSWSGMIS REELRRSSFL QAVSQLEVEP ..DINRMTSF FSYEHFYVIY
PR59/B”G2   FHSRYITT.. ..VIQRIFYT VNRSWSGMIS REELRRSSFL QAVSQLEVEP ..DINRMTSF FSYEHFYVIY
PR59/B”G3   RHGSPVTPPL FQVIQRIFYT VNRSWSGMIS REELRRSSFL QAVSQLEVEP ..DINRMTSF FSYEHFYVIY
G5PR/B”J FYSFYVCT.. ..AVRKFFFF LDPLRTGKIK IQDILACSFL DDLLELRDEE LSKESQETNW FSAPSALRVY
980
PR130/B”D1  CKFWELDGDH DLYISQADLS RYNDQASSNR IIERIFSGAV TRGKTVQKEG RMSYADFVWF LISEEDKRNP
PR72/B”D2  CKFWELDGDH DLYISQADLS RYNDQASSNR IIERIFSGAV TRGKTVQKEG RMSYADFVWF LISEEDKRNP
PR59/B”G1   CKFWELDLDR DLTIDRSDLA RHGDGAISSR MIDRIFSGAV TRARLPRKVG KLSYADFVWF LLSEEDKTTP
PR59/B”G2   CKFWELDLDR DLTIDRSDLA RHGDGAISSR MIDRIFSGAV TRARLPRKVG KLSYADFVWF LLSEEDKTTP
PR59/B”G3   CKFWELDLDR DLTIDRSDLA RHGDGAISSR MIDRIFSGAV TRARLPRKVG KLSYADFVWF LLSEEDKTTP
G5PR/B”J GQYLNLDKDH NGMLSKEELS RYGTATMTNV FLDRVFQECL TY......DG EMDYKTYLDF VLALENRKEP
1050
PR130/B”D1  TSIEYWFRCM DVDGDGILSM YELEYFYEEQ CERMEAMGIE PLPFHDLLCQ MLDLVKPASD GRITLRDLKR
PR72/B”D2  TSIEYWFRCM DVDGDGILSM YELEYFYEEQ CERMEAMGIE PLPFHDLLCQ MLDLVKPASD GRITLRDLKR
PR59/B”G1   TSTEYWFRCM DLDGDGALSM FELEFFYEEQ AQRMAARGVE PLPFHDLARQ VLDLVAPRCP GRITLRDLKQ
PR59/B”G2   TSTEYWFRCM DLDGDGALSM FELEFFYEEQ AQRMAARGVE PLPFHDLARQ VLDLVAPRCP GRITLRDLKQ
PR59/B”G3   TSTEYWFRCM DLDGDGALSM FELEFFYEEQ AQRMAARGVE PLPFHDLARQ VLDLVAPRCP GRITLRDLKQ
G5PR/B”J AALQYIFKLL DIENKGYLNV FSLNYFFRAI QELMKIHGQD PVSFQDVKDE IFDMVKPKDP LKISLQDLIN
1120
PR130/B”D1  CRMAHIFYDT FFNLEKYLDH EQRDPFAVQK DVENDGPEPS DWDRFAAEEY EALVTEESAQ VQLQEGSFED
PR72/B”D2  CRMAHIFYDT FFNLEKYLDH EQRDPFAVQK DVENDGPEPS DWDRFAAEEY EALVTEESAQ VQLQEGSFED
PR59/B”G1   CGLAGEFFDA FFNVDKYLAR EQREQAGTPQ DTDSD.PAAS AWDRYAAEEY DFLVAEEA.. ..MAEDDDDH
PR59/B”G2   CGLAGEFFDA FFNVDKYLAR EQREQAGTPQ DTDSD.PAAS AWDRYAAEEY DFLVAEEA.. ..MAEDDDDH
PR59/B”G3   CGLAGEFFDA FFNVDKYLAR EQREQAGTPQ DTDSD.PAAS AWDRYAAEEY DFLVAEEA.. ..MAEDDDDH
G5PR/B”J SNQGDTVTTI LIDLNGFWTY ENREALVAND NENSADLDDT .......... .......... ..........
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PR130/B”D1  YESDEPVSPS ELGNKGNKIV TSSLSEKCGK LQSVDEE 
PR72/B”D2  YESDEPVSPS ELGNKGNKIV TSSLSEKCGK LQSVDEE
PR59/B”G1  DEGSDPIDLY GLADEDCDDL EPL....... .......
PR59/B”G2  DEGSDPIDLY GLADEDCDDL EPL....... .......
PR59/B”G3  DEGSDPIDLY GLADEDCDDL EPL....... .......
G5PR/B”J .......... .......... .......... .......
70
PR130/B”D1M AATYRLVVS TVNHYSSVVI DRRFEQAIHY CTGTCHTFTH GIDCIVVHHS VCADLVHIPV SQFKDVDLNS
PR130/B”D1  VFLSHENGLS SAEDYPHQAL TGLPRGKKAS TFQNTCNLKD IAGEAISFAS GKIKEFSLEK LRNSNHAAYR
PR130/B”D1 KGRKVKSDSF NRRSVDFDLL CGHYNNDGTS PPFGLLRSSS VEEKSLSHRN SLDTNLTSML FQNLSEEDLV
PR130/B”D1 TQILEKHKID HFSSGTDIKM CLDILLKCSE DLKKCTDIIK QCIKKKSGGS ISEGSGNEVI SNSETVYMNV
PR130/B”D1 MTRLAYYLRK LPFEFMQSGN NETVDLTELI NNIPNLQLTP FSPLYGTEQP PKYEDIVHLS ALDSGQFQTV
PR130/B”D1 ELQDDKHNFK QTDIVKTTPN NTDSLCSLEV NDPGTLKPVQ LQSPLLTINH LENVSSGNLM ETLYIEEESD
PR130/B”D1 GKKSLLDKEQ KAENGQGQEP LQVNEHKEFS DHDTYLKKCP VSMQNEIGKI FEKPIMVHPS KEDSKLEVPT
PR130/B”D1 TDLRDQRHFV NPNSQEEIDK LLMDLESFSQ KMETSLGEPL AKGKSINSLN SHSHLTAQSH KDLEPKPIAS
630
PR130/B”D1  SAMEKVSPSC LTRIIENNGH KMEEEDRALL LRIMESIEDF AQELVECKSG RGSLSQEKEM MQILQETLTT
PR72/B”D2  .......... .......... .......... .......... .......... .......... MMIKETSLRR
PR59/B”G1 .......... .......... .........M APLTPRLQLK VDELF..RRW LGDPHTQRAL SHALRRI.RD
PR59/B”G2   .......... .......... .......... .......... .......... ....MPERPP IRALRRD.PD
PR59/B”G3   .......... .......... .......... .......... .......... .......... ..........
G5PR/B”J .......... .......... .......... .......... MDWKDVLRRR LASPNTDPKR KKSEQELKDE
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PR59/B”G1   PGTTSDPAAA ATPDADPGNT TSDPNPASRP LPRPALRTTG PRTVHAHRKE EPPPQSPPPG HSVPA.....
PR59/B”G2   DPAVAQALAS LARGSD.... LVFPSRFQKW L.......RD FRQVHAHRKE EPPPQSPPPG HTVPA.....
PR59/B”G3   .......... .......... .......... .......... .......... .......... ..........
G5PR/B”J EMDLFTKYYS EWKGGRKNTN EFYKTIPRFY YRLPAEDEVL LQKLREESRA VFLQRKSREL LDNEELQN..
770
PR130/B”D1  NTPLSINIPQ FYFPEGLPDT C.SNHEQILS RIETAFKDIE DQKADIHEMG RIAKVCGCPL YWKAPMFRAA
PR72/B”D2  NTPLSINIPQ FYFPEGLPDT C.SNHEQILS RIETAFKDIE DQKADIHEMG RIAKVCGCPL YWKAPMFRAA
PR59/B”G1   .......... FYFPCGRPPP RPQDTEDAIA LVECAFEGLP RGRAGLGDMA VVAKACGCPL YWKAPLFYAA
PR59/B”G2   .......... FYFPCGRPPP RPQDTEDAIA LVECAFEGLP RGRAGLGDMA VVAKACGCPL YWKAPLFYAA
PR59/B”G3   .......... .......... .......... .......... .......... .......... ..........
G5PR/B”J .......... LWFLLDKHQI PPMIGEEAMI NYEN.FLKVG EKAGPKCKQF FTAKVF.... ...AKLLHTD
840
PR130/B”D1  GGEKTGFVTA QSFIAMWKKL LSNRHDDAAK FIWLLAKPSC SYLEQEDFIP LLQDVVDTHP GLTFLKDAPE
PR72/B”D2  GGEKTGFVTA QSFIAMWKKL LSNRHDDAAK FIWLLAKPSC SYLEQEDFIP LLQDVVDTHP GLTFLKDAPE
PR59/B”G1   GGERTGSVSV HMFVAMWRKV LLTCHDDAAR FVRLLGHPGC SGLIQEDFVP FLQDVVNSHP GLAFLRAAKD
PR59/B”G2   GGERTGSVSV HMFVAMWRKV LLTCHDDAAR FVRLLGHPGC SGLIQEDFVP FLQDVVNSHP GLAFLRAAKD
PR59/B”G3   .........M PLTPPIAVRF TVNPSDPALT PPTALG.PAH TALTLTVITA LALPLMPGHT HSPHINYSDS
G5PR/B”J SYGRISI..M QFFNYVMRKV WLHQTRIGLS LYDVAGQ... GYLRESDLEN YILELIPTLP QLDGLE..KS
910
PR130/B”D1  FHSRYITT.. ..VVQRIFYT VNRSWSGKIT STEIRKSNFL QTLALLEEEE ..DINQITDY FSYEHFYVIY
PR72/B”D2  FHSRYITT.. ..VVQRIFYT VNRSWSGKIT STEIRKSNFL QTLALLEEEE ..DINQITDY FSYEHFYVIY
PR59/B”G1   FHSRYITT.. ..VIQRIFYT VNRSWSGMIS REELRRSSFL QAVSQLEVEP ..DINRMTSF FSYEHFYVIY
PR59/B”G2   FHSRYITT.. ..VIQRIFYT VNRSWSGMIS REELRRSSFL QAVSQLEVEP ..DINRMTSF FSYEHFYVIY
PR59/B”G3   RHGSPVTPPL FQVIQRIFYT VNRSWSGMIS REELRRSSFL QAVSQLEVEP ..DINRMTSF FSYEHFYVIY
G5PR/B”J FYSFYVCT.. ..AVRKFFFF LDPLRTGKIK IQDILACSFL DDLLELRDEE LSKESQETNW FSAPSALRVY
980
PR130/B”D1  CKFWELDGDH DLYISQADLS RYNDQASSNR IIERIFSGAV TRGKTVQKEG RMSYADFVWF LISEEDKRNP
PR72/B”D2  CKFWELDGDH DLYISQADLS RYNDQASSNR IIERIFSGAV TRGKTVQKEG RMSYADFVWF LISEEDKRNP
PR59/B”G1   CKFWELDLDR DLTIDRSDLA RHGDGAISSR MIDRIFSGAV TRARLPRKVG KLSYADFVWF LLSEEDKTTP
PR59/B”G2   CKFWELDLDR DLTIDRSDLA RHGDGAISSR MIDRIFSGAV TRARLPRKVG KLSYADFVWF LLSEEDKTTP
PR59/B”G3   CKFWELDLDR DLTIDRSDLA RHGDGAISSR MIDRIFSGAV TRARLPRKVG KLSYADFVWF LLSEEDKTTP
G5PR/B”J GQYLNLDKDH NGMLSKEELS RYGTATMTNV FLDRVFQECL TY......DG EMDYKTYLDF VLALENRKEP
1050
PR130/B”D1  TSIEYWFRCM DVDGDGILSM YELEYFYEEQ CERMEAMGIE PLPFHDLLCQ MLDLVKPASD GRITLRDLKR
PR72/B”D2  TSIEYWFRCM DVDGDGILSM YELEYFYEEQ CERMEAMGIE PLPFHDLLCQ MLDLVKPASD GRITLRDLKR
PR59/B”G1   TSTEYWFRCM DLDGDGALSM FELEFFYEEQ AQRMAARGVE PLPFHDLARQ VLDLVAPRCP GRITLRDLKQ
PR59/B”G2   TSTEYWFRCM DLDGDGALSM FELEFFYEEQ AQRMAARGVE PLPFHDLARQ VLDLVAPRCP GRITLRDLKQ
PR59/B”G3   TSTEYWFRCM DLDGDGALSM FELEFFYEEQ AQRMAARGVE PLPFHDLARQ VLDLVAPRCP GRITLRDLKQ
G5PR/B”J AALQYIFKLL DIENKGYLNV FSLNYFFRAI QELMKIHGQD PVSFQDVKDE IFDMVKPKDP LKISLQDLIN
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PR59/B”G2   CGLAGEFFDA FFNVDKYLAR EQREQAGTPQ DTDSD.PAAS AWDRYAAEEY DFLVAEEA.. ..MAEDDDDH
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addition, no human EST-clones were retrieved containing
the PR130-specific N-terminus followed by nucleotides
other than those of the common part of PR130 and PR72.
To unravel the genomic organisation of the murine PR59
gene (MGI: 1335093), we analysed NCBI contig
NW_001030923. Currently, this gene's symbol is Ppp2r3a,
Table 1: Exon-intron organisation of the murine PR72/B" genes.
Ppp2r3a exon exon size (bp) 5'-splice donor intron size (bp) 3'-splice acceptor
12 4 3 4 A T C A A G gtaaga 4838 tcttagATTAGA
29 8 A G G T C T gtaacc 7123 tcccagAAGGCT
3 441 ACACAGgtttga 4205 ttccagATTCAA
4 267 GCAAAGgtaaca 8122 ttgcagGTCTGT
5 104 GAAAAAgtaagt 5495 ttgtagGTTGCT
6 103 CTTCAGgtgata 4932 ttaagGATGTG
7 75 ACCACGgtagga 21453 aactagGTTGTT
8 87 TTGCAAgtatgc 5049 tttcagACTCTG
91 5 7 A C C A G G gtaagt 3058 atttagCTTCAT
10 49 AACAAGgtatga 1074 cttcagAGGAAA
11 90 TACCAGgtaaag 17238 tcctagCATTGA
12 176 GTGATGgtaagg 469 tcatagGCAGAA
13 119 CAGAAGgtaaca 1179 aatcagGATGTT
14a 107 AGAAGG / GTGAGT
14b 1174 GAGATAgtcctc 15879 ttccagCTCATT
15 1575
Ppp2r3c exon exon size (bp) 5'-splice donor intron size (bp) 3'-splice acceptor
1 866 CAAAGAgtgagt 3572 tactagGGAAAA
2 128 TACAGGgtaagt 378 tttaagTTGCCA
3 105 TTGCAGgtacga 520 cttaagAACTTA
4 113 GTGCAAgtaaga 3898 ttttagGCAATT
5 98 GAAAAGgtgatt 1207 tgtcagTTTGGC
6 71 GAATCAgtgagt 2711 tcccagGACCTG
7 133 GAACAGgtaaaa 913 cccaagGGAAGA
8 156 CTGGAGgtaaat 76 ctttagCTAAGA
9 76 TCTATGgtaggc 381 tgcaagGTCAGT
10 137 GAAATGgtagtt 3006 ctgtagGACTAT
11 138 TTTAGGgtaagt 1803 atacagGCCATA
12 60 GTCAAGgttatt 1108 ttatagGATGAA
13 982
Ppp2r3d exon exon size (bp) 5'-splice donor intron size (bp) 3'-splice acceptor
1 567 CAGGACggtgag 358 gcacagACCCGA
2 321 CGGCAGgtgggc 405 ccacagGTCCAT
3 198 GCCAAGgtatgt 298 ccccagGCCTGT
4 105 CGCAAGtgagtg 409 acagagTCCTGC
5 101 CTGCAGgtgggc 672 tggcagGATGTG
6a 75 ACCACA / GTGAGC
6b 373 TTCCAG / GTGATT
6c 87 CTGCAGgtgtgg 452 ctgcagGCTGTG
7 157 AGCGGGgtgagt 260 ccgcagCCATCT
8 49 CACCAGgtgagt 276 ccgcagGGCGAG
99 0 C A C C A G gtgagg 402 ccacagCACCGA
10 176 GCCCCGgtgagc 220 ccccagGCCGGA
11 119 CCGCAGgtgggt 412 ccacagGACACT
12 113 CGAAGGgttaga 296 tcacagGCCCTG
13a 37 CCCAG / GTCCGA
13b 256
Nucleotides in uppercase represent exonic sequences while nucleotides in lowercase represent intronic sequences. Bold letters indicate the exon-
intron boundaries based on the AT-GT rule.BMC Genomics 2008, 9:393 http://www.biomedcentral.com/1471-2164/9/393
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Organisation of the murine B"-encoding genes and their transcripts Figure 3
Organisation of the murine B"-encoding genes and their transcripts. The boxes represent the exons (on scale) and 
the lines represent the introns (not on scale). The coding regions (black boxes) and untranslated regions (white boxes) are 
indicated. Splicing events are denoted by dotted lines. Below the genomic structures, all putative transcripts are indicated: the 
main transcripts are coloured in black (at least 5 EST clones were retrieved), while less abundant transcripts are coloured in 
grey (less than 5 EST clones were found). Primers used for RT-PCR are also indicated (forward primers: B72, B130, Bδ1, Bδ2 and 
Bδ3/4; reverse primers: E1 to E9).
Ppp2r3a (former name: 3222402P14Rik) PR72/130
1 2 3 4 5 6 7 8 9 10 1112 1314a 15 14b
PR130/B” 1
PR130/B” 3
PR72/B” 2
PR72/B” 4
1 4 5 6 7 8 9 101112 1314a 15
12
3 4 5 6 7 8 9 101112 1314a 15
3 4 5 6 7 8 9 101112 1314a 14b
Ppp2r3d (former name: Ppp2r3a) PR59
PR59/B” 1
PR59/B” 2
PR59/B” 3
PR59/B” 4
1 2 3 4 5 6a b c 7 8 9 10 111213a b
1 3 4 5 6a 7 8 9 10 1112 13b 6c
3 4 5 6a 7 8 9 10 1112 13b 6c 2
6b 7 8 9 10 1112 13b 6c
6b 7 8 9 10 1112 13ab 6c
BG1 BG2 BG3/4 E1 E2
E3
B130 B72
E5
E6 E8
E9 E4
E7
Ppp2r3c  G5PR
12 3 4 5 6 7 8 9 1 0 1 1 1 2 1 3BMC Genomics 2008, 9:393 http://www.biomedcentral.com/1471-2164/9/393
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but as one could easily mistake it for the murine ortho-
logue of PPP2R3A, we propose to change its name into
Ppp2r3d (see also further). This gene spans approximately
9 kb and consists of 13 exons. The exons encoding the
complete sequences of all mPR59 isoforms were found at
the appropriate locations (Figure 3). To find the human
Ppp2r3d  homologue, we scanned the human genome
using the BLASTN program with the different mPR59 iso-
forms as input. The closest match was the human PR70/
PPP2R3L product gene (PPP2R3B/L), followed by the
human PR130/PR72 gene (PPP2R3A), confirming the
similarity between PR70/PPP2R3L and mPR59 at the
genomic level. Therefore, the murine Ppp2r3d  and the
human PPP2R3B/L gene may have evolved from a com-
mon ancestor gene. This hypothesis looks promising since
to our knowledge no organism contains both a PR70/
PPP2R3L product and a PR59-encoding gene. A phyloge-
netic tree, based on the protein sequences of various
PR72/B" family members in man and mouse, further sup-
ports this hypothesis (Figure 4).
Analysis of the mG5PR genomic structure is based on
NCBI contig NW_001030500, which is located on chro-
mosome 12C2 (56 Mb, ENSEMBLE ContigView) and con-
tains the entire gene (Ppp2r3c, MGI: 193009). The mG5PR
gene (Figure 3) contains 13 exons and closely mimics the
genomic organisation of the human gene [9].
The mPR59/B"δ3 protein is not a genuine PP2Aregulatory 
subunit
With the exception of XN73 and mPR130/B"α3, all B"
family members contain a conserved region and specific
N- and C-termini. The conserved region, which contains
two ASBDs and two EF-hand motifs, is necessary for
PR65/A binding [3]. Since the first ASBD is not intact in
mPR59/B"δ3 (Figure 2), we wondered whether this iso-
form is still able to bind PP2A. To this end, we made GST-
fusion proteins of the main B" family members and over-
expressed these in COS-7 cells. After a GST-pull down
assay, we evaluated the binding of both the PR65/A and
catalytic subunit of PP2A via Western blotting. As
expected, all main B" isoforms (hPR130, hPR72, hPR70,
mG5PR/B"γ, mPR59/B"δ1 and mPR59/B"δ2) bind PP2A
(Figure 5), and are therefore genuine B" subunits. In con-
trast, mPR59/B"δ3 fails to bind PP2A, suggesting it is not
a regulatory subunit of PP2A (Figure 5). Like XN73 and
mPR130/B"α3, it might be involved in regulation of PP2A
by competing with the other mPR59 isoforms for binding
to other binding partners.
Phylogenetic tree (MULTALIN) Figure 4
Phylogenetic tree (MULTALIN). Phylogenetic tree 
based on protein sequence of human and murine B" regula-
tory subunits (human and murine PR72/B"α2 [Gen-
Bank:NP_871626 and BAE21013], human and murine PR130/
B''α1 [GenBank:Q06190 and XP_135153], murine PR59/
B''δ1,2,3 [GenBank:AAH59852, AAC98973 and BAE25309], 
human PR70 [GenBank:DAA00385], human PPP2R3L prod-
uct [GenBank:CAI41975], human and murine G5PR/B''γ 
[GenBank:BAA91308, NP_067504].
Association of the main human and murine PR72/B" isoforms  with PP2AD Figure 5
Association of the main human and murine PR72/B" 
isoforms with PP2AD. COS7 cells were transfected with 
GST, hPR130-GST, hPR72-GST, hPR70-GST, mG5PR/B"γ-
GST, mPR59/B"δ1-GST, mPR59/B"δ2-GST and mPR59/B"δ3-
GST. 48 h after transfection, a GST pull down assay was per-
formed and binding of PR65/A and C subunits was evaluated 
via Western blotting using specific antibodies.
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Tissue distribution of mPR130/B"α1, mPR72/B"α2, 
mPR59/B"δ1 and mPR59/B"δ2
We determined the mRNA expression of the genuine
murine B" regulatory subunits via Northern blot analysis
(Figure 6). Using an antisense probe which hybridises to
the first 330 nucleotides of mPR130, transcripts of 4.3 kb
and 7.0 kb were detected. These transcripts are probably
generated by the use of different polyadenylation sites.
However, we can not exclude the possibility that the 4.3
kb transcript represents mPR130/B"α3. Both mPR130
transcripts have a similar expression pattern, being high in
kidney and heart, intermediate in skeletal muscle, brain,
liver and testis and low in lung and spleen. These findings
are consistent with the previously published ubiquitous
expression of human PR130 [6].
A probe specific for the N-terminal sequence of the
mPR72 isoforms, detected a single band at 4.4 kb, likely
corresponding to mPR72/B"α2. Similar to the expression
pattern of PR72 in humans [6], mPR72/B"α2 is abundant
in heart and skeletal muscle and barely detectable in other
tissues (Figure 6).
As for mPR130/B"α1 and mPR72/B"α2, the transcripts of
mPR59/B"δ1 and mPR59/B"δ2 were visualised using
probes hybridising with their specific N-termini. The
expression profiles obtained reveal a wide tissue distribu-
tion with some minor differences between the two splice
variants: mPR59/B"δ1 expression is high in heart and
liver, intermediate in kidney, brain and skeletal muscle
and rather low in testis, lung and spleen, while mPR59/
B"δ2 is highly abundant in heart, liver, brain, kidney and
testis and less abundant in lung, skeletal muscle and
spleen.
These results, together with the earlier observed broad
mG5PR expression pattern [9] indicate a general high
expression of all murine PP2A B" subunits in heart.
Embryonic expression of the murine B" regulatory subunits
In order to generate viable knockout mice, it can be
important to establish whether a function of the protein
of interest can be expected during embryonic develop-
ment, as a general knockout of such a gene might lead to
an embryonic lethal phenotype. Expression of the
mPR130/B"α1, mPR72/B"α2, mPR59/B"δ1, mPR59/
B"δ2 and mG5PR/B"γ subunits was examined via North-
ern blotting at embryonic days 7, 11, 15 and 17 (Figure 7).
Hybridisation was performed using the same specific
probes as for the tissue distribution determination. For
mG5PR/B"γ, a probe spanning the first 450 nucleotides of
mG5PR/B"γ was used. No additional splice variants, spe-
cific for embryonic stages, were observed for any of the
main murine B" subunits. Expression of both mPR130/
B"α1 and mPR72/B"α2 transcripts increases as embryonic
development proceeds. This might suggest a role for these
proteins in fetal growth and development. In previous
studies, both hPR130 as well as hPR72 have been reported
to influence Wnt signalling [15-17]. In contrast, the
expression of mPR59/B"δ1, mPR59/B"δ2 and mG5PR/
B"γ remains constant during all stages of embryonic devel-
opment (Figure 7).
Immunohistochemical analysis of mPR130/B"α1 and 
mPR72/B"α2 in different muscle tissues
All B" isoforms are highly expressed in heart. Moreover,
mPR72/B"α2 expression is nearly restricted to muscle tis-
sue. mPR130/B"α1, which has a broader expression pat-
tern, is also substantially present in the different muscle
tissues represented on the Northern blot. Since we have
specific antibodies for both isoforms (Figure 1B), we
examined the distribution of mPR130/B"α1 and mPR72/
B"α2 in the different types of muscle tissue (heart, skeletal
and smooth muscle) in more detail via immunohisto-
chemistry.
In longitudinal sections of skeletal muscle, mPR130/B"α1
and mPR72/B"α2 both intensively stain the muscle fibers
in a striated pattern (Figure 8A, e–f). To evaluate whether
these bands represent the I- or A-bands, we counterstained
the sections with iron hematoxylin. This dye gives the A-
band a dark blue colour and colocalises with mPR130/
B"α1 and mPR72/B"α2 (Figure 8B, f–g). In one of the
muscle fibers stained with mPR130/B"α1 AB, we could
even observe a darker stained band positioned in the cen-
tre of the A-band (Figure 8B, d). This band probably rep-
resents the H-zone. In sections of murine myocardium, a
similar striated staining pattern could be observed in the
longitudinally positioned muscle fibers. Cross-sectional
muscle fibers did not show staining of any specific struc-
tures (Figure 8A, h–i). In bladder, neither mPR130/B"α1
AB nor mPR72/B"α2 AB stained the smooth muscle fibers
of the muscular layer. In contrast, mPR130/B"α1 staining
could be seen in the transitional epithelial layer, lining the
inner cavity of the bladder (Figure 8A, b–c). In none of the
cases, specific staining of any structures was observed
using pre-immune serum (Figure 8A, a,d,g).
In conclusion, PR130/B"α1 and PR72/B"α2 staining
seems to be a specific feature of the A-band striations of
heart and skeletal muscle, whereas staining is very low or
absent in smooth muscle.
Subcellular localisation of the murine B" subunits
Using GFP-fusion proteins, we determined the subcellular
localisation of the hPR72, mPR59/B"δ1, mPR59/B"δ2,
mG5PR/B"γ and hPR70 subunits in COS7 cells. Since the
PR130 AB is suitable for direct immunofluorescence, we
also evaluated the subcellular localisation of endogenous
PR130 (Figure 9). As previously described [11], hPR72 isBMC Genomics 2008, 9:393 http://www.biomedcentral.com/1471-2164/9/393
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Tissue distribution of the murine PR130/B"α1, PR72/B"α2, PR59/B"δ1/2 transcripts Figure 6
Tissue distribution of the murine PR130/B"α1, PR72/B"α2, PR59/B"δ1/2 transcripts. A first choice Mouse Blot I 
containing poly(A+) RNAs from ten different murine tissues (Clontech) was hybridised with isoform-specific RNA probes. For 
quantification we used the ImageQuant program from Molecular Dynamics. Percentages of expression are relative to the most 
intense band on each blot, which was given a value of 100%. Therefore only transcripts present on the same blot can be com-
pared. A β-actin control hybridisation is shown at the bottom.
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mainly present in the nucleus (N >> CP). PR130 is present
in both the cytoplasm and the nucleus (N > CP). mPR59/
B"δ1 (CP = N) and mPR59/B"δ2 (CP > N) appear both in
cytoplasm and nucleus but are clearly less abundant in the
nucleus than hPR72 and PR130. mG5PR/B"γ is more
abundant in the nucleus than the cytoplasm (N > CP),
corresponding to earlier published data [9], and addition-
ally is highly abundant in the cell periphery. Surprisingly,
unlike PR48 [20], hPR70 has a more pronounced cyto-
plasmic expression (CP >> N). This diversity in observed
subcellular localisation patterns demonstrates that each
B" subunit may direct the phosphatase to distinct sites
and substrates within the cell.
All B" subunits tested provoke a G1 arrest upon 
overexpression
Several B" family members have been suggested to influ-
ence cell cycle progression [9-11,13,14,20]. Therefore we
analysed the cell cycle profile of HeLa cells upon overex-
pression of several EGFP-B" fusion-proteins via FACS
analysis. Compared to control cells (EGFP), overexpres-
sion of all EGFP-B" fusion proteins tested (hPR72,
hPR130, hPR70, mG5PR/B"γ, mPR59/B"δ1 and mPR59/
B"δ2) caused an increase in the G1 population of trans-
fected cells (Figure 10A). This was even more pronounced
in the presence of nocodazole, which arrests cycling cells
in G2/M (Figure 10B). These results confirm and extend
previously published effects of hPR72 [11] and mPR59/
B"δ2 [10] overexpression on cell cycle progression.
Discussion
The importance of the B-type subunits for PP2A regula-
tion can hardly be overestimated as they restrict PP2A
activity spatially and temporarily within living organisms,
thereby determining PP2A substrate selectivity and func-
tion. Although the B-type subunits can be classified into
three distinct gene families (PR55/B, PR61/B' and PR72/
B"), their still increasing number, the sometimes confus-
ing nomenclature and species-specific differences add to
the complexity, especially for the non-specialist. In partic-
ular, for the PR72/B" subunit family the current situation
may be confusing. With the aim to make this more clear
and at the same time to provide a platform for the gener-
ation of B" knockout mice, we have presented here a com-
prehensive overview of the murine B" family members-in
analogy to previous reports of the murine B' [25] and B
[24] families.
In addition to the previously described murine-specific
PR59 subunit [10] and the murine orthologues of PR130,
PR72 and G5PR, we have identified two novel splice vari-
ants of mPR59 as members of the murine B" family. Based
on the genomic organisation of the Ppp2r3d  gene, we
named the original isoform PR59/B"δ2 and the novel iso-
forms PR59/B"δ1 and PR59/B"δ3. In contrast to PR59/
B"δ1 and δ2, no in vivo interaction of PR59/B"δ3 with
PP2A could be observed. Consequently, PR59/B"δ3 can
not be considered as a regulatory subunit of PP2A. In
addition, other potential murine B" family members
(mPR130/B"α3, mPR72/B"α4 and mPR59/B"δ4) were
found to be present in the NCBI EST database. Although
genomic evidence for these isoforms could be found, our
attempts to confirm their existence at either the mRNA or
protein level failed. This suggests that these isoforms are
poorly expressed or might result from splicing errors. Nev-
ertheless, we can not exclude the possibility that their
expression is missed because of a tight regulation or
restriction in space and/or time. Moreover, the existence
of two B" isoforms (PR130/B"α3 and PR59/B"δ3) which
Expression pattern of the main murine B" regulatory subunits  in embryos Figure 7
Expression pattern of the main murine B" regulatory 
subunits in embryos. A murine embryo multiple tissue 
Northern Blot containing poly(A+) RNAs from murine 
embryos at days 7, 11, 15 and 17 (Clontech) was hybridised 
with isoform-specific RNA probes. Embryonic expression of 
mPR130/B"α1, mPR72/B"α2, mPR59/B"δ1, mPR59/B"δ2 and 
mG5PR/B"γ is shown. For quantification we used the Image-
Quant program from Molecular Dynamics. Percentages of 
expression are relative to the most intense band of the 
murine tissues blot (Figure 6). This way, a comparison with 
the relative expression of a specific isoform in the different 
tissues (Figure 6) can be made. The β-actin control hybridisa-
tion is shown at the bottom and was used to correct for 
equal loading.
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Immunohistochemistry of mPR130/B"α1 and mPR72/B"α2 in muscle tissue (heart, skeletal muscle and smooth muscle) Figure 8
Immunohistochemistry of mPR130/B"α1 and mPR72/B"α2 in muscle tissue (heart, skeletal muscle and 
smooth muscle). A: Sections of bladder (a-c), skeletal muscle (d-f) and heart (g-i) were costained with the nuclei-specific 
hematoxylin dye (blue) and antibodies specific for mPR130/B"α1 (b, e, h) or mPR72/B"α2 (c, f, i). As a control, sections were 
stained with pre-immune sera (a, d, g). B: Staining of longitudinal sections of skeletal muscle with iron hematoxylin (a, b), 
PR130-specific AB (c,d), PR72-specific AB (e) and costaining with iron hematoxylin and PR130 AB (f) or PR72 AB (g).
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do not interact with the PP2A core dimer, gives further
support to the idea that B" subunits can exist- and be sta-
ble-independently of PP2A and that their function might
extend beyond regulation of phosphatase activity as such
(see [4] for a discussion). Even if so far only minute
amounts of these atypical unexpected messages could be
detected, specific conditions might lead to an upregula-
tion and possible functional consequences.
To our surprise, no murine orthologues of human PR70
or PPP2R3L product could be found. These gene products
arise from the PPP2R3B/L  gene, and according to the
genomic organisation of PPP2R3B/L, we propose to
rename these two N-terminal splice variants PR70/B"β1
and PR70/B"β2 respectively (Table 2). Several arguments
suggest that the murine Ppp2r3d gene (PR59) originates
from a common ancestor of the human PPP2R3B/L gene
(PR70), the Canis familiaris PPP2R3B gene (PR70) and the
Xenopus laevis LOC398610 gene (PR70): (1) none of these
organisms contain both the genes responsible for the
expression of PR59 and PR70 isoforms; (2) these genes
share the highest degree of homology amongst the B"
members, both on the protein as well as on the genomic
level; (3) from both genes, two B" regulatory subunits
arise by using alternative first exons; and (4) human
PR70/B"β1 can interact with and regulate the phosphor-
ylation status of pRb while murine PR59/B"δ2 can associ-
ate with and regulate the phosphorylation status of p107,
another member of the retinoblastoma family [10].
Therefore, they may share some functional similarities.
Despite these similarities, we do not consider PR59 as the
murine orthologue of PR70. This is based on (1) the
rather low sequence homology between the specific N-ter-
minal regions of the different PR59 and PR70 isoforms
and (2) the ubiquitous expression of both PR59 regula-
tory subunits in contrast to the skeletal muscle and heart-
specific expression of hPR70/B"β2[8]. For these reasons,
we suggested to rename the PR59-encoding gene Ppp2r3d,
instead of Ppp2r3b. Because of the diversity between mice
and humans, it can be concluded that in contrast with the
PP2A PR55/B and PR61/B' families, the PR72/B" family
represents a less evolutionary conserved group of pro-
teins. However, this does not mean that this family is not
represented in lower species. PR72/B" members are also
found in Xenopus laevis [7], Drosophila melanogaster [Gen-
Bank:NM_142585],  Caenorhabditis elegans [Gen-
Bank:XM_001667031], various plants (Arabidopsis
thaliana  [GenBank:AF290025],  Oryza sativa [Gen-
Bank:AC078829]), and some unicellular organisms (Tet-
rahymena thermophila [GenBank:XP_001015505],
Paramecium tetraurelia [GenBank:XP_001347004]), but
are manifestly absent in yeast.
Unlike the PR55/B and PR61/B' family, the nomenclature
of both the genes and proteins of the PR72/B" family
Subcellular localisation of the main PR72/B" regulatory subu- nits in COS-7 cells Figure 9
Subcellular localisation of the main PR72/B" regula-
tory subunits in COS-7 cells. Endogenous PR130 was vis-
ualised using PR130N rec. AB, while the other main B" 
regulatory subunits (hPR72, hPR70, mG5PR/B"γ, mPR59/
B"δ1 and mPR59/B"δ2) were visualised as EGFP fusion pro-
teins. Pictures were taken with a LSM-510 laser scanning 
confocal microscope.
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Cell cycle profile of EGFP, hPR72-EGFP, hPR130-EGFP, hPR70-EGFP, mG5PR/B"γ-EGFP, mPR59/B"δ1-EGFP and mPR59/B"δ2- EGFP expressing HeLa cells Figure 10
Cell cycle profile of EGFP, hPR72-EGFP, hPR130-EGFP, hPR70-EGFP, mG5PR/B"γ-EGFP, mPR59/B"δ1-EGFP 
and mPR59/B"δ2-EGFP expressing HeLa cells. 48 h after transfection with the different expression plasmids, HeLa cells 
were stained for DNA content (propidium iodide), and the cell cycle profile of EGFP-positive cells was measured. Panel A con-
tains untreated cells whereas cells of panel B were treated with nocodazole (16 h, 1 mg/ml) prior to analysis. Quantification of 
the percentages of cells in G1, S and G2/M stages of the cell cycle are included. These are results from one typical experiment. 
Each condition was performed at least 4 times giving similar results but the outcome was highly dependent on the 
(over)expression level.
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members became very confusing. As mentioned earlier,
we propose to change the murine PR72/B" gene names in
such a way that the relationship with their human coun-
terparts becomes clearer (Table 2). As for the PR72/B" pro-
t e i n s ,  u n t i l  n o w ,  m o s t  o f  t h e m  h a v e  b e e n  n a m e d
according to their molecular weight (with G5PR as an
exception to this rule). In this report, we would like to
propose a nomenclature which is in accordance with the
corresponding gene name and the organisation of that
gene, and is consistent with the nomenclature of the pro-
teins of the PR55/B and PR61/B' families. For historical
reasons we prefer to keep the original and commonly
known PR130, PR72, PR70, PR59 and G5PR protein
names combined with the B" indication and an addi-
tional specification (Greek letter) to denote the specific
isoform. As such, B" proteins encoded by the PPP2R3A
gene (PR130 and PR72) will get the 'α' extension, fol-
lowed by a number to designate the specific splice variant;
B" proteins encoded by the PPP2R3B gene (PR70) get the
'β' extension etc. For the comfort of the authors and read-
ers, once in a manuscript the subunit is clearly defined,
the short names B"α1, B"γ1 etc. can be used. In Table 2, a
summary of the (old and new) murine and human B"
nomenclature is given. If one intents to indicate the whole
family, one can use PR72/B" as a common denominator
since this makes an unequivocal distinction with the other
B-type third subunits: PR55/B and PR61/B'.
We have also investigated the tissue distribution and
developmental expression of all murine PP2A PR72/B"
subunits on the RNA level. Taking together previously
published data [6-8] and our northern blot analyses, it can
be concluded that mPR130/B"α1, hPR130/B"α1, mPR59/
B"δ1, mPR59/B"δ2, mG5PR/B"γ and XPR70/B"β1 are
ubiquitously expressed, indicating that these subunits are
involved in general cellular processes. In contrast,
mPR72/B"α2, hPR72/B"α2, and hPR70/B"β2 are highly
expressed in heart and skeletal muscle and barely detecta-
ble in other tissues, suggesting a specific role for these sub-
units in striated muscle tissues. In fact, all B" subunits
seem to be highly expressed in heart, an observation
which is given the presence of two EF-hands in their pri-
mary structures and their regulation by Ca2+ ions, of par-
ticular interest.
Immunohistochemical analysis of longitudinal fibers of
murine heart and skeletal muscle showed a striated pat-
tern for mPR130/B"α1 and mPR72/B"α2. Counterstain-
ing with iron hematoxylin revealed that they both
colocalise with the A-band. In contrast to the I-band, the
A-band does not only contain thin, actin-rich filaments
but also thick, myosine-rich filaments. mPR130/B"α1 and
mPR72/B"α2 staining is virtually absent in the smooth
muscle of the bladder, suggesting that these subunits may
play a specific role in striated muscle contraction only.
Although mPR130/B"α1 and mPR72/B"α2 stain the
nuclei in longitudinal as well as cross sections of heart and
skeletal muscle, their nuclear localisation in these tissues
is less pronounced compared to cultured fibroblast cell
lines, probably due to their relatively high abundance in
the contractile apparatus.
During embryogenesis no significant differences in
expression from E7 until E17 could be observed for tran-
Table 2: Proposed nomenclature of PP2A PR72/B" regulatory subunits in Homo sapiens and Mus musculus.
GENE SYMBOL PROTEIN
HUMAN MOUSE HUMAN MOUSE
name alias (new) name alias new name alias new name alias
PPP2R3A PPP2R3 Ppp2r3a 3222402P14Rik PR130/B"α1 PR130 PR130/B"α1P R 1 3 0
PR72/B"α2 PR72 PR72/B"α2P R 7 2
PR130/B"α3
PR72/B"α4
PPP2R3B NY-REN-8 -- PR70/B"β1 PR70* --
PPP2R3L PR70/B"β2 PPP2R3L product * --
PPP2R3C C14orf10 Ppp2r3c MGC55473 G5PR/B"γ G5PR G5PR/B"γ G5PR
-- Ppp2r3d AI118493 -- PR59/B"δ1
-- PR59/B"δ2m P R 5 9
- - PR59/B"δ3
- - PR59/B"δ4
bold: main PR72/B" regulatory subunits
*: protein of which first a partial clone, PR48, was discoveredBMC Genomics 2008, 9:393 http://www.biomedcentral.com/1471-2164/9/393
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scripts of mG5PR/B"γ, mPR59/B"δ1 and mPR59/B"δ2,
indicating that the expression of these proteins is not reg-
ulated during early embryonic development. Meanwhile,
mPR130/B"α1 and mPR72/B"α2 expression increases
from E7 to E17. This might imply a role for these proteins
during early embryogenesis. Alternatively, protein levels
of these isoforms are simply building up for a more max-
imal expression during late development or after birth. In
accordance with this increased expression during embryo-
genesis, depletion of XPR72 in Xenopus embryos caused
several severe developmental defects (defects in somite
formation, a short axis phenotype and lack of eye differ-
entiation) [15]. Depletion of XPR130 resulted in milder
developmental defects such as a disruption of somite
organisation and an underdeveloped tail [16]. Together
these data provide valuable information that will aid in
the development of suitable strategies to generate future
B" knockout mice, as well as in their phenotypic analysis.
At the cellular level, we have also determined the subcel-
lular localisation of the main murine and human B" sub-
units via expression of EGFP-fusion proteins in COS7 cells
(for PR72/B"α2, G5PR/B"γ, PR70/B"β1, PR59/B"δ1 and
PR59/B"δ2) or via indirect immunofluorescence (for
PR130/B"α1). A high diversity was observed: whereas
PR130/B"α1, PR72/B"α2 and G5PR/B"γ are predomi-
nantly nuclear, PR59/B"δ1 is equally well expressed in the
cytoplasm, and PR70/B"β1 and PR59/B"δ2 are predomi-
nantly expressed in the cytoplasm. The latter observation
further extends the relationship and functional homology
between these two isoforms. On the other hand, the cyto-
plasmic localisation of PR70/B"β1 is in contrast with the
reported nuclear localisation of its truncated PR48 form
[20], suggesting that nuclear import/export of PR70 iso-
forms may be a regulated event. Further, putative nuclear
localisation signals are predicted in G5PR/B"γ (mono-
and bipartite), PR130/B"α1 and PR72/B"α2 (monopar-
tite), but not in PR59/B"δ1, PR59/B"δ2 or PR70/B"β1,
whereas a nuclear export signal is predicted in the com-
mon part of PR59/B"δ1 and PR59/B"δ2. Although the
functionality of these motifs remains to be determined,
their putative occurrence/absence fits quite well with our
experimental observations.
Upon overexpression, all B" subunits tested can induce a
G1/S cell cycle arrest in HeLa cells, suggesting that this
property may be independent of their subcellular localisa-
tion. The failure to proceed to S-phase may be related to
the suggestion that many B" subunits play roles in DNA
replication [9,10,13,14,20]. However, the mechanism of
this induced cell cycle arrest may equally well be the result
of a dominant negative effect, such as for instance a com-
petition between 'free' B" [11] and trimeric B" for binding
a substrate, or competition between B" and other B-type
subunits for binding to PP2AD.
Conclusion
In conclusion, the murine PR72/B" family exhibits an
equal complexity and diversity as the PR55/B and PR61/
B' families of PP2A subunits, with three genes encoding
nine isoforms/splice variants, of which at least five are
abundantly expressed and give rise to genuine PP2A sub-
units. An important difference with the PR55/B and PR61/
B' families however, is the poorer relationship between
human and murine genes, which might indicate that the
B" family is evolutionary more divergent. Moreover, the
diversity of PR72/B" members does not only originate
from the number of isoforms, but extends to their specific
tissue distribution, developmental expression and subcel-
lular localisation. These differences add to the notion that
no matter how similar their primary structures may be,
different PP2A B-type isoforms likely display different in
vivo functions. To explore these functions in mouse mod-
els remains an exciting challenge for the future.
Methods
Materials
[35S]-Methionine (2.5 mCi/ml), [32P]UTP, Protein G
Sepharose and Glutathione Sepharose beads were
obtained from Amersham Pharmacia Biotech. Restriction
enzymes and DNA-modifying enzymes were purchased
from Fermentas. Pwo proofreading polymerase (used in
all PCR reactions) was from Roche Molecular Biochemi-
cals. DNA oligonucleotides were purchased from Sigma-
Genosys.
Bioinformatics
To search for the murine B" homologues in public data-
bases we used the Nucleotide BLAST programs at NCBI
http://blast.ncbi.nlm.nih.gov/Blast.cgi. For the alignment
of proteins and generation of a phylogenetic tree, we used
the multalin program http://bioinfo.genopole-tou
louse.prd.fr/multalin/multalin.html. Percentages of simi-
larity and identity between the amino acid sequence of
two proteins were calculated using EMBOSS Pairwise
alignment algorithm http://www.ebi.ac.uk/emboss/align.
Data regarding the localisation of genes on the murine
chromosomes were obtained using the ENSEMBLE Con-
tig View http://www.ensembl.org/index.html, while the
corresponding regions in human chromosomes were
found using the ENSEMBLE Synteny View. Putative
nuclear localisation signals have been predicted using the
PSORT program http://psort.ims.u-tokyo.ac.jp, whereas
putative nuclear export signals were predicted using the
NetNES 1.1 Server http://www.cbs.dtu.dk/services/
NetNES.
Antibodies
Anti-GST monoclonal antibody was purchased from
Sigma. Anti PP2AC and anti-PR65 monoclonal antibodies
were generously supplied by Dr. S. Dilworth (ImperialBMC Genomics 2008, 9:393 http://www.biomedcentral.com/1471-2164/9/393
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College, London, UK). Anti-PR72N pept. antibody was a
generous gift of Dr. B. Hemmings (FMI, Basel, CH). Anti-
PR72rec. antibody has been previously described [11]. For
the generation of the anti- PR130 N rec. antibody, BL21-
pLys(RP) E. coli cells were transformed with PR130 AA1-
664 in pET15b and induced with 0.2 mM IPTG overnight
at 16°C. The inclusion bodies were purified [11], solubi-
lised in 7 M guanidinium hydrochloride, and dialysed
against 200 mM Tris. HCl pH 8.2 containing 0.5 M NaCl.
The resulting protein solution was used to immunise rab-
bits (Unité d'Hormonologie, Marloie, Belgium). The
antiserum was taken after 5 boosts with the antigen and
used at 1/2000 for Western blotting and 1/100 for
immunofluorescence. Before immunisation a sample of
the preimmune serum was taken as a negative control.
RNA isolation and RT-PCR
Total RNA from NIH 3T3 cells and murine heart tissue
was isolated using GenElute™ Mammalian Total RNA Kit
(Sigma) and reverse transcribed using primer E3 (5'-CTG
TGC GCC CAG GAA CTG CGC-3') for the mPR59 iso-
forms and primers E5 (5'-CCT TGC AGT CCT CTT CCA
CCA GC-3'), E7 (5'-GAT TCT GTC AGG GCT CTA GCA
GG-3') and E9 (5'-GGA TGC TGT GTA GAG ATG CTC
TAG-3') for the mPR72/130 isoforms. The following
primers were used to amplify the different mPR59 iso-
forms: B"δ1 (5'-CTC TGC CAT CAG TCT CTG CCC-3'),
Bδ2 (5'-CAG GCC ACA CCC ACG GAT TCG-3'), B"δ3/4
(5'-CCA CAG GGT CTT CAG CCA CGC-3'), E1 (5'-GCC
CTG CCC ACT CTG ACT ATG-3') and E2 (5'-GAC GAC
CTG GAG CCT CTG TGA-3'). The primers used to amplify
the different mPR72/130 isoforms are B130 (5'-ATG GCA
GCA ACT TAC AGA CTT GTG-3'), B72 (5'-ATG ATC AAG
GAA ACG TCC TTG CGA AG-3'), E4 (5'-CTG TTG CTT
GGG CAG CCT GAC C-3'), E6 (5'-AGG TTC AGC TCC
AAG AAG GGT GA-3') and E8 (5'-CTT CAG TCA GTG GAT
GAA GAG TAG-3'). The approximate location of the vari-
ous primers within the genes is indicated in Figure 3.
In vitro transcription-translation
[35S]-Methionine-labelled proteins were obtained from
pBluescript vectors containing the coding regions of the
proteins, using the TNT-coupled rabbit reticulocyte lysate
system (Promega) with the appropriate RNA polymerase
(T3/T7).
Immunoprecipitation of tissue extracts
Wild-type mice were anaesthetised with an intraperito-
neal injection of pentobarbital (Nembutal, CEVA), tran-
scardially perfused with ice-cold saline (NaCl 0.9%, B
Braun) and dissected tissues were freeze clamped in liquid
nitrogen. Tissues were weighed and homogenised on ice
within a threefold volume excess of homogenisation
buffer (25 mM Tris pH 7.6, 150 mM NaCl, 1 mM EDTA
and 1 mM EGTA) containing protease inhibitors (Com-
plete Protease Inhibitor Cocktail, Roche) using a douncer
with 20–30 strokes. The homogenates were centrifuged
for 10' at 13,000 g and the supernatant was collected.
After preclearing with protein G-Sepharose (Amersham
Biosciences), tissue lysates were incubated overnight at
4°C with anti-PR72N rec., anti-PR130N rec. or anti-PR72N
pept.. After addition of 40 μl of protein G-Sepharose for 1
h, the immune complexes were washed 4 times with 1 ml
TBS + 0.1% Nonidet P-40 before they were dissolved in
Laemmli sample buffer. Bound proteins were separated
by SDS/PAGE and transferred to nitrocellulose mem-
branes. Individual proteins were detected with the speci-
fied antibodies, revealed by horseradish peroxidase-
linked secondary antibodies (DAKO) and developed
using the ECL kit (Amersham Biosciences).
GST-pull down
Monkey COS7 cells were transfected (FuGENE 6, Roche)
with pGMEX-T1, hPR72/B"α2-pGMEX, hPR130/B"α1-
pGMEX, hPR70/B"β1-pGMEX, mPR59/B"δ1-pGMEX,
mPR59/B"δ2-pGMEX, mPR59/B"δ3-pGMEX and
mG5PR/B"γ-pGMEX in a 10-cm dish. 48 h after transfec-
tion, cells were rinsed with phosphate-buffered saline
(PBS), lysed in 200 μl NET buffer (50 mM Tris pH 7.4, 150
mM NaCl, 15 mM EDTA and 1% NP-40) and centrifu-
gated for 10' at 13,000 g. Cell lysates were incubated at
4°C for 1 h with NENT200 buffer (20 mM Tris-HCl pH 7.4,
1 mM EDTA, 0.1% Nonidet P-40, 25% glycerol, 200 mM
NaCl) containing 1 mg/ml bovine serum albumin and 25
μl glutathione-Sepharose beads (Amersham Biosciences)
on a rotating wheel. The beads were washed 2 times with
1 ml of NENT300 (NENT with 300 mM NaCl) containing
1 mg/ml bovine serum albumin and 2 times with 1 ml of
NENT300. Bound proteins were eluted by addition of 20 μl
of Laemmli sample buffer and boiling. The eluted pro-
teins were analysed by SDS-PAGE and Western blotting.
Construction of isoform-specific RNA probes
To generate isoform-specific PCR products, we used fol-
lowing primers: 5'-ATG ATC AAG GAA ACG TCC TTG
CGA AG-3' and 5' GAA GAG GCT GAA GTC ATT TCA G-
3', generating mPR72/B"α2 nt 1–120; 5'-ATG GCA GCA
ACT TAC AGA CTT GTG-3' and 5'-GAA TAC CTG TAA CTT
AAA GGA C-3', resulting in mPR130/B"α1 nt 1–330; 5'-
atg gac tgg a aa gac gtg ctt c-3' and 5'-gcc aaa ctc ctt cat aca
gat-3', producing mG5PR/B"γnt 1–450; 5'-ATG GCG CCG
CTG ACG CCG CGG-3' and 5'-GAA CGA CGG GAC CCA
GGA CG-3', producing mPR59/B"δ1 nt 1–243; and 5'-
AGG CCA CAC CCA CGG ATT CG-3' and GTT TCC GTC
GCG CTT CCA GAA G-3', resulting in mPR59/B"δ2 54 nt
5'UTR + nt 1–120 of coding region. We subcloned these
PCR products into the pBluescript II SK-vector (Strata-
gene). The constructs were used to generate RNA probes.
The RNA probes were transcribed and labeled withBMC Genomics 2008, 9:393 http://www.biomedcentral.com/1471-2164/9/393
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[32P]UTP using Ambion's Strippable RNA probe synthesis
and removal kit.
Northern blotting
A Mouse Tissue MTN® Blot containing poly(A+) RNA from
eight murine tissues and a Mouse Embryo MTN® Blot con-
taining poly(A+) RNA from murine embryos at days 7, 11,
15 and 17 were obtained from Clontech Laboratories. The
membranes were hybridised at 64°C using Ambion's Ult-
rahyb Ultrasensitive hybridisation buffer and washed
with Northern Max Low and High Stringency Buffers from
Ambion. They were exposed and analysed using Image-
Quant (Molecular Dynamics). Probe removal was done
using Ambion's Strippable RNA probe synthesis and
removal kit. For quantification we used the ImageQuant
program from Molecular Dynamics. Absolute values of
the different tissues and embryonic stages were first
divided by the absolute β-actin values of the correspond-
ing tissue/embryonic stages. These values where then
compared with the value of the most intense band on the
tissue blot, which was given a value of 100%.
Subcellular localisation
PCR fragments of hPR72/B"α2, hPR70/B"β1, mG5PR/
B"γ, mPR59/B"δ1 and mPR59/B"δ2 were cloned into the
SmaI restriction site of pEGFP-C1 (Clontech). 1 μg of each
plasmid was transfected into COS7 cells grown on a glass
coverslip in a 12-well dish. 24 h after transfection, cells
were washed in PBS and fixed in PBS containing 4% para-
formaldehyde for 10 min. After 3 washes with PBS, cells
were mounted in Prolong gold antifade reagent with DAPI
(Invitrogen). For immunofluorescence staining of endog-
enous PR130, COS7 cells grown on a glass coverslip were
rinsed with PBS and fixed in PBS with 4% paraformalde-
hyde for 10 min. Subsequently, cells were incubated with
PBS containing 1% bovine serum albumin (BSA, Sigma)
for 30 min and then for 45 min with the PR130N rec. pri-
mary antibodies, followed by incubation with Alexa Fluor
488 donkey anti-rabbit secondary antibody (Invitrogen)
in PBS with 1% BSA. Finally, the cells were washed 3 times
in PBS, once in water and mounted in Prolong gold anti-
fade reagent with DAPI (Invitrogen). All slides were exam-
ined with a LSM-510 laser scanning confocal microscope
(Zeiss, Jena, Germany), using a Plan-Neofluar 40×/1.6 Oil
DIC objective.
FACS Analysis
Asynchronously growing HeLa cells were transfected with
pEGFP-C1 or the GFP fusion plasmids of the different B"
subunits in two 10-cm dishes per plasmid. If nocodazole
(1 μg/ml) was used, it was added at this point for another
16 h before FACS analysis. 48 h after transfection, cells
were trypsinised, washed in PBS and fixed for 5 min in 4%
paraformaldehyde at room temperature. After washing,
the cell pellet was incubated in 0.5 ml of PBS containing
100 μg/ml propidium iodide (Fluka) and 0.1% RNase for
at least 1 h at room temperature. The samples were ana-
lysed with a Beckman Instruments Coulter Epics XL flow
cytometer (Analis) on FL1 (for EGFP) and FL3 (for pro-
pidium iodide) using standard procedures, and the Sys-
tem II™ software (Analis) and WinMDI Version 2.8
software for quantification.
Immunohistochemistry
Wild-type mice were anaesthetised with pentobarbital
(Nembutal, CEVA) and transcardially perfused with PBS
containing 4% paraformaldehyde. Organs were removed,
postfixed overnight at 4°C and paraffin embedded. Sec-
tions (7 μM) were mounted on silan coated glass slides
(Menzel gläser). For antigen retrieval, dewaxed and rehy-
drated tissue sections were boiled in 10 mM citric acid
(pH 6.0) for 10 min. After cooling the slides, endogenous
peroxidase was removed with 0.03% H2O2 in methanol
for 20 min and transferred to PBS solution. Subsequently,
sections were encircled with a water-repellent PAP-pen
(Zymed) and rinsed with PBS. After blocking with PBS
containing 1% BSA for 45 min, sections were immunore-
acted for 1 h at RT with primary antibodies, washed 3
times with PBS containing 0.05% Tween (PBS-T), incu-
bated with biotinylated goat anti-Rabbit secondary anti-
body (Vector Labs) at RT for 30 min, and washed three
times with PBS-T. After incubation for 30 min with the
VECTASTAIN ABC Systems (Vector Labs), sections were
washed 3 times in PBS-T, incubated with diaminobenzi-
dine tetrahydrochloride (1 tablet dissolved in 10 ml 50
mM Tris pH 7.6, MP Biomedicals), washed three times in
water and incubated with hematoxylin (Sigma) or iron
hematoxylin (Sigma) for 2 min. Next, sections were
washed in tap water for 5', dehydrated and mounted using
Depex. Tissue sections were examined using a light micro-
scope equipped with a digital camera (DC200, Leica
Microsystems).
List of abbreviations
AB (antibody), ASBD (A subunit binding domain), CG-
NAP (centrosome and Golgi localized PKN-associated
protein), DARPP-32 (dopamine- and cAMP-regulated
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hPR130 (human PR130), PKA (protein kinase A), mPR59
(murine PR59), PKN (novel protein kinase), PP1 (protein
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